Publications by authors named "Dlamini Sindisiwe"

Article Synopsis
  • The study investigates the prevalence of monoclonal gammopathy of undetermined significance (MGUS) in Eswatini, comparing it with data from Olmsted County, Minnesota, to understand its impact, particularly among Black individuals.
  • A total of 515 plasma samples from a nationally representative survey showed a 13.2% prevalence of MGUS, with findings indicating that while overall MGUS rates are similar between Eswatini and Olmsted County, light-chain MGUS is significantly higher in Eswatini.
  • The results suggest that current definitions of light-chain MGUS may need reevaluation, particularly in the context of untreated HIV infections, as they could be reflecting different underlying conditions.
View Article and Find Full Text PDF

Background: Lack of point-of-care testing (POCT) for sexually transmitted infections (STIs) is a continuing missed opportunity in Sub-Saharan Africa. We assessed feasibility and acceptability of STI POCT in Eswatini.

Methods: Sexually transmitted infection POCT for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) was piloted among sexually active adults 18 to 45 years old attending 2 urban outpatient clinics offering integrated services.

View Article and Find Full Text PDF

As antiretroviral treatment (ART) coverage for people living with HIV (PLHIV) increases, HIV programmes require up-to-date information about evolving HIV risk behaviour and transmission risk, including those with low-level viremia (LLV; >50 to ≤1000 copies/mL), to guide prevention priorities. We aimed to assess differences in sexual risk behaviours, distribution of viral load (VL) and proportion of transmission across PLHIV subgroups. We analysed data from Population-based HIV Impact Assessment surveys in 14 sub-Saharan African countries during 2015-2019.

View Article and Find Full Text PDF

Identifying persons who have newly acquired HIV infections is critical for characterizing the HIV epidemic direction. We analyzed pooled data from nationally representative Population-Based HIV Impact Assessment surveys conducted across 14 countries in Africa for recent infection risk factors. We included adults 15-49 years of age who had sex during the previous year and used a recent infection testing algorithm to distinguish recent from long-term infections.

View Article and Find Full Text PDF

The US President's Emergency Plan for AIDS Relief (PEPFAR) supports molecular HIV and tuberculosis diagnostic networks and information management systems in low- and middle-income countries. We describe how national programs leveraged these PEPFAR-supported laboratory resources for SARS-CoV-2 testing during the COVID-19 pandemic. We sent a spreadsheet template consisting of 46 indicators for assessing the use of PEPFAR-supported diagnostic networks for COVID-19 pandemic response activities during April 1, 2020, to March 31, 2021, to 27 PEPFAR-supported countries or regions.

View Article and Find Full Text PDF
Article Synopsis
  • Despite a deworming program initiated in 2000, the intestinal parasitic infection (IPI) rate among primary schoolchildren in Eswatini remained high at 40.5% in a 2010 study, with notable differences between provinces (28.8% in Manzini and 58.3% in Lubombo).
  • Protozoa were the most common pathogens, making up 20.6% of infections, while helminths had a very low infection rate of just 1.6%.
  • Factors such as poor personal hygiene and unsafe water sources were significant risk factors, highlighting the need for enhanced treatments and interventions by the Eswatini Health Authority to better address persistent IPI issues among children.
View Article and Find Full Text PDF

Background: Stool is an important diagnostic specimen for tuberculosis in populations who struggle to provide sputum, such as children or people living with HIV. However, the culture of Mycobacterium tuberculosis (M. tuberculosis) complex strains from stool perform poorly.

View Article and Find Full Text PDF

Background: HIV-1 incidence calculation currently includes recency classification by HIV-1 incidence assay and unsuppressed viral load (VL ≥ 1000 copies/mL) in a recent infection testing algorithm (RITA). However, persons with recent classification not virally suppressed and taking antiretroviral (ARV) medication may be misclassified.

Setting: We used data from 13 African household surveys to describe the impact of an ARV-adjusted RITA on HIV-1 incidence estimates.

View Article and Find Full Text PDF

Background: Measurement of mother-to-child HIV transmission through population-based surveys requires large sample sizes because of low HIV prevalence among children. We estimate potential improvements in sampling efficiency resulting from a targeted sample design.

Setting: Eight countries in sub-Saharan Africa with completed Population-based HIV Impact Assessment (PHIA) surveys as of 2017.

View Article and Find Full Text PDF

Background: To assess the performance and suitability of dried blood spot (DBS) sampling using filter paper to collect blood for viral load (VL) quantification under routine conditions.

Methods: We compared performance of DBS VL quantification using the Biocentric method with plasma VL quantification using Roche and Biocentric as reference methods. Adults (≥18 years) were enrolled at 2 health facilities in Eswatini from October 12, 2016 to March 1, 2017.

View Article and Find Full Text PDF

Background: Viral load (VL) testing is being scaled up in resource-limited settings. However, not all commercially available VL testing methods have been evaluated under field conditions. This study is one of a few to evaluate the Biocentric platform for VL quantification in routine practice in Sub-Saharan Africa.

View Article and Find Full Text PDF

A quantifiable, stool-based, () test has potential complementary value to respiratory specimens. Limit of detection (LOD) was determined by spiking control stool. Clinical test performance was evaluated in a cohort with pulmonary tuberculosis (TB) ( = 166) and asymptomatic household TB child contacts ( = 105).

View Article and Find Full Text PDF

Background: Swaziland introduced rotavirus vaccine in the National Immunization Program, in May 2015, with the objective of reducing the burden of rotavirus diarrheal disease. We monitored the early impact of the vaccine in reducing rotavirus diarrhea.

Methods: We conducted sentinel rotavirus surveillance from January 2013 to December 2016 in children under five years of age admitted due to diarrhea attending Mbabane Government Referral Hospital in the Hhohho Region and Raleigh Fitkin Memorial Hospital in the Manzini Region.

View Article and Find Full Text PDF